Who Paid My Doc
Michael Ruma
Maternal & Fetal Medicine Albuquerque, NM Medical Doctor
NPI 1609910900 CMS profile 254838
201 Cedar St Se, #405, Albuquerque, NM 87106
General payments
$888,756
Research payments
$93,150
Ownership & investment interest
$0
Research they led as principal investigator
$126,139
Through program year 2025, Michael Ruma of Albuquerque, NM is reported in the CMS Open Payments database as having received $888,756 across 430 general payments and $93,150 in research payments paid to them. Separately, studies naming them as principal investigator received $126,139 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Maternal & Fetal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
10 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $91,366 | 65 | |
| 2025 | Research | $3,720 | 1 | |
| 2024 | General | $181,188 | 78 | |
| 2023 | General | $167,782 | 94 | |
| 2022 | General | $171,427 | 67 | |
| 2021 | General | $132,798 | 33 | |
| 2020 | General | $63,737 | 25 | |
| 2020 | Research | $17,210 | 3 | |
| 2019 | General | $80,459 | 68 | |
| 2019 | Research | $72,220 | 14 |
Beside peers
- Michael Ruma
- Maternal & Fetal Medicine median
- Middle half of Maternal & Fetal Medicine
- National median
In program year 2025, general payments to Michael Ruma were reported at $91,366. Among 891 Maternal & Fetal Medicine profiles paid that year, the median was $56 and the middle half received between $25 and $146.
Show as a table
| Year | Michael Ruma | Maternal & Fetal Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $80,459 | $70 | $23–$148 | $163 |
| 2020 | $63,737 | $51 | $18–$141 | $114 |
| 2021 | $132,798 | $43 | $20–$137 | $132 |
| 2022 | $171,427 | $48 | $22–$145 | $149 |
| 2023 | $167,782 | $53 | $24–$150 | $160 |
| 2024 | $181,188 | $68 | $25–$159 | $164 |
| 2025 | $91,366 | $56 | $25–$146 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
448 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Maternal & Fetal Medicine in New Mexico
Jose Gonzalez Sanchez
Maternal & Fetal Medicine · Albuquerque, NM
Conrad Chao
Maternal & Fetal Medicine · Albuquerque, NM
Steffen Brown
Maternal & Fetal Medicine · Albuquerque, NM
Trevor Quiner
Maternal & Fetal Medicine · Albuquerque, NM
Joses Jain
Maternal & Fetal Medicine · Albuquerque, NM
Christopher Cox
Maternal & Fetal Medicine · Albuquerque, NM
Related records
Maternal & Fetal Medicine in New Mexico
Practitioners in the same specialty and state, ranked by reported value.
All Maternal & Fetal Medicine
Everyone recorded under this specialty, nationwide.
Doctors in New Mexico
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.